BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
Apoptosis
,
HIV infection
,
Retina
,
Laser capture microdissection
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Rho GTPase-activating protein domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dorsal root ganglia
Medulla oblongata
Subthalamic nucleus
Amygdala
Trigeminal ganglia
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Listeriosis
Vesicular stomatitis Indiana virus disease
Bacterial infection due to Bacillus
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
P79 protein, human
JM 3100
GSK-1059615
CGP 60474
SB 525334
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TICAM1
NRF1
NCL
NR5A1
MIR122
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Dicer1 knockout gene expression during Schwann cell development
miRNA expression profiles from osteosarcoma samples and cell lines
Follicular fluid miRNA profiles during the development of the oocyte
Circulating miRNA in serum of Wilms tumor patients
Kidneys from male C57BL6 mice 28 days after left proximal ureter ligations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Rho GTPase-activating protein domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of the Pathophysiological Mechanisms Involved in Bleeding Events
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ